{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:09:22Z","timestamp":1791828562529,"version":"4.3.4"},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T00:00:00Z","timestamp":1574208000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0215192","type":"journal-article","created":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T13:24:50Z","timestamp":1574256290000},"page":"e0215192","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":24,"title":["Circulating Th17.1 cells as candidate for the prediction of therapeutic response to abatacept in patients with rheumatoid arthritis: An exploratory research"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5455-8670","authenticated-orcid":true,"given":"Shinji","family":"Maeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Osaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyo","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihisa","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-ya","family":"Tamechika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taio","family":"Naniwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Niimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,11,20]]},"reference":[{"key":"pone.0215192.ref001","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"JS Smolen","year":"2016","journal-title":"Lancet"},{"key":"pone.0215192.ref002","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/art.30129","article-title":"American College of Rheumatology\/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials","volume":"63","author":"DT Felson","year":"2011","journal-title":"Arthritis Rheum"},{"key":"pone.0215192.ref003","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/art.24392","article-title":"Defining remission in rheumatoid arthritis: results of an initial American College of Rheumatology\/European League Against Rheumatism consensus conference","volume":"61","author":"LHD Van Tuyl","year":"2009","journal-title":"Arthritis Rheum"},{"key":"pone.0215192.ref004","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"IB McInnes","year":"2007","journal-title":"N Engl J Med"},{"key":"pone.0215192.ref005","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1056\/NEJMoa035075","article-title":"Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig","volume":"349","author":"JM Kremer","year":"2003","journal-title":"N Engl J Med"},{"key":"pone.0215192.ref006","doi-asserted-by":"crossref","first-page":"865","DOI":"10.7326\/0003-4819-144-12-200606200-00003","article-title":"Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial","volume":"144","author":"JM Kremer","year":"2006","journal-title":"Ann Intern Med"},{"key":"pone.0215192.ref007","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3899\/jrheum.091066","article-title":"Abatacept for rheumatoid arthritis: A cochrane systematic review","volume":"37","author":"LJ Maxwell","year":"2010","journal-title":"J Rheumatol"},{"key":"pone.0215192.ref008","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1084\/jem.20062259","article-title":"T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis","volume":"204","author":"K Hirota","year":"2007","journal-title":"J Exp Med"},{"key":"pone.0215192.ref009","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1084\/jem.20071397","article-title":"Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model","volume":"204","author":"K Hirota","year":"2007","journal-title":"J Exp Med"},{"key":"pone.0215192.ref010","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/nature07036","article-title":"Induction and effector functions of T(H)17 cells","volume":"453","author":"E Bettelli","year":"2008","journal-title":"Nature"},{"key":"pone.0215192.ref011","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/ng.583","article-title":"A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility","volume":"42","author":"Y Kochi","year":"2010","journal-title":"Nat Genet"},{"key":"pone.0215192.ref012","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cyto.2015.02.002","article-title":"The role and modulation of CCR6+ Th17 cell populations in rheumatoid arthritis","volume":"74","author":"SMJ Paulissen","year":"2015","journal-title":"Cytokine"},{"key":"pone.0215192.ref013","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1084\/jem.20130301","article-title":"Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids","volume":"211","author":"R Ramesh","year":"2014","journal-title":"J Exp Med"},{"key":"pone.0215192.ref014","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jaut.2017.12.006","article-title":"Molecular mechanisms underpinning T helper 17 cell heterogeneity and functions in rheumatoid arthritis","volume":"87","author":"JP van Hamburg","year":"2018","journal-title":"J Autoimmun"},{"key":"pone.0215192.ref015","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1093\/rheumatology\/keh333","article-title":"Corticosteroid resistance in rheumatoid arthritis: molecular and cellular perspectives","volume":"43","author":"IC Chikanza","year":"2004","journal-title":"Rheumatology"},{"key":"pone.0215192.ref016","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.immuni.2017.02.006","article-title":"Immunopathogenesis of rheumatoid arthritis","volume":"46","author":"GS Firestein","year":"2017","journal-title":"Immunity"},{"key":"pone.0215192.ref017","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/rheumatology\/kex012","article-title":"Differential effects of biological DMARDs on peripheral immune cell phenotypes in patients with rheumatoid arthritis","volume":"57","author":"S Nakayamada","year":"2018","journal-title":"Rheumatology"},{"key":"pone.0215192.ref018","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrrheum.2015.71","article-title":"Immune cell profiling to guide therapeutic decisions in rheumatic diseases","volume":"11","author":"J Ermann","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"pone.0215192.ref019","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/rheumatology\/kex283","article-title":"Toward cellular biomarkers for rheumatoid arthritis","volume":"57","author":"J Falconer","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"pone.0215192.ref020","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"FC Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"pone.0215192.ref021","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1136\/ard.2006.054205","article-title":"Comparison of Disease Activity Score (DAS)28-erythrocyte sedimentation rate and DAS28-C-reactive protein threshold values","volume":"66","author":"E Inoue","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"pone.0215192.ref022","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1002\/sim.5705","article-title":"The performance of different propensity score methods for estimating marginal hazard ratios","volume":"32","author":"PC Austin","year":"2013","journal-title":"Stat Med"},{"key":"pone.0215192.ref023","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/oxfordjournals.aje.a010011","article-title":"Invited commentary: propensity scores","volume":"150","author":"MM Joffe","year":"1999","journal-title":"Am J Epidemiol"},{"key":"pone.0215192.ref024","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s12185-010-0581-1","article-title":"Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia: a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry","volume":"91","author":"K Nagafuji","year":"2010","journal-title":"Int J Hematol"},{"key":"pone.0215192.ref025","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics","volume":"48","author":"Y Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"pone.0215192.ref026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v009.i08","article-title":"Analysis of complex survey samples","volume":"9","author":"T Lumley","year":"2004","journal-title":"J Stat Soft"},{"key":"pone.0215192.ref027","doi-asserted-by":"crossref","DOI":"10.1007\/978-0-387-98141-3","volume-title":"ggplot2: elegant graphics for data analysis","author":"H Wickham","year":"2009"},{"key":"pone.0215192.ref028","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nri3158","article-title":"Standardizing immunophenotyping for the Human Immunology Project","volume":"12","author":"HT Maecker","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"pone.0215192.ref029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2017.12.007","article-title":"A cellular and molecular view of T helper 17 cell plasticity in autoimmunity","author":"R Stadhouders","year":"2018","journal-title":"Journal of Autoimmunity"},{"key":"pone.0215192.ref030","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jaut.2017.12.003","article-title":"TH17\u202fcell plasticity: The role of dendritic cells and molecular mechanisms","author":"T Agalioti","year":"2018","journal-title":"Journal of Autoimmunity"},{"key":"pone.0215192.ref031","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1016\/j.celrep.2018.02.044","article-title":"IL-23 and IL-1\u03b2 Drive Human Th17 Cell Differentiation and Metabolic Reprogramming in Absence of CD28 Costimulation","volume":"22","author":"S Revu","year":"2018","journal-title":"Cell Rep"},{"key":"pone.0215192.ref032","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13075-017-1305-1","article-title":"Differences in serum and synovial CD4+ T cells and cytokine profiles to stratify patients with inflammatory osteoarthritis and rheumatoid arthritis","volume":"19","author":"A Penatti","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"pone.0215192.ref033","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1136\/annrheumdis-2013-204816","article-title":"MOR103, a human monoclonal antibody to granulocyte\u2013macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib\/IIa randomised, double-blind, placebo-controlled, dose-escalation trial","volume":"74","author":"F Behrens","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"pone.0215192.ref034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005087","article-title":"CD28 co-stimulation down regulates Th17 development","volume":"4","author":"S Bouguermouh","year":"2009","journal-title":"PLoS One"},{"key":"pone.0215192.ref035","first-page":"1034","article-title":"Co-stimulatory and Co-inhibitory Pathways in Autoimmunity","volume":"44","author":"Q Zhang","year":"2016","journal-title":"Immunity. Elsevier Inc."},{"key":"pone.0215192.ref036","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.4049\/jimmunol.0903369","article-title":"Cutting Edge: CTLA-4\u2013B7 Interaction Suppresses Th17 Cell Differentiation","volume":"185","author":"H Ying","year":"2010","journal-title":"J Immunol"},{"key":"pone.0215192.ref037","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/ajt.12600","article-title":"High CTLA-4 expression on Th17 cells results in increased sensitivity to CTLA-4 coinhibition and resistance to belatacept","volume":"14","author":"SM Krummey","year":"2014","journal-title":"Am J Transplant"},{"key":"pone.0215192.ref038","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1126\/science.1160062","article-title":"CTLA-4 control over Foxp3+ regulatory T cell function","volume":"322","author":"K Wing","year":"2008","journal-title":"Science"},{"key":"pone.0215192.ref039","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1126\/science.270.5238.985","article-title":"Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4","volume":"270","author":"P Waterhouse","year":"1995","journal-title":"Science"},{"key":"pone.0215192.ref040","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/1074-7613(95)90125-6","article-title":"Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4","volume":"3","author":"EA Tivol","year":"1995","journal-title":"Immunity"},{"key":"pone.0215192.ref041","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.4049\/jimmunol.1600737","article-title":"Ex-Th17 (nonclassical Th1) cells are functionally distinct from classical Th1 and Th17 cells and are not constrained by regulatory T cells","volume":"198","author":"SA Basdeo","year":"2017","journal-title":"J Immunol"},{"key":"pone.0215192.ref042","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3109\/14397595.2013.854051","article-title":"Abatacept inhibits radiographic progression in patients with rheumatoid arthritis: a retrospective analysis of 6 months of abatacept treatment in routine clinical practice, The ALTAIR Study","volume":"24","author":"S Kubo","year":"2014","journal-title":"Mod Rheumatol"},{"key":"pone.0215192.ref043","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3109\/14397595.2015.1123211","article-title":"Postmarketing surveillance of the safety and effectiveness of abatacept in Japanese patients with rheumatoid arthritis","volume":"26","author":"M Harigai","year":"2016","journal-title":"Mod. Rheumatol"},{"key":"pone.0215192.ref044","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1136\/annrheumdis-2011-201109","article-title":"Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the \u201cOrencia and rheumatoid arthritis\u201d registry","volume":"71","author":"JE Gottenberg","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"pone.0215192.ref045","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1136\/ard.2010.140129","article-title":"Efficacy of abatacept and tocilizumab in patients with rheumatoid arthritis treated in clinical practice: results from the nationwide Danish DANBIO registry","volume":"70","author":"HC Leffers","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"pone.0215192.ref046","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s10067-016-3185-1","article-title":"Predictive factors of abatacept therapy discontinuation in patients with rheumatoid arthritis","volume":"35","author":"S Piantoni","year":"2016","journal-title":"Clin Rheumatol"},{"key":"pone.0215192.ref047","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.3899\/jrheum.110386","article-title":"Baseline numbers of circulating CD28-negative T cells may predict clinical response to abatacept in patients with rheumatoid arthritis","volume":"38","author":"M Scarsi","year":"2011","journal-title":"J Rheumatol"},{"key":"pone.0215192.ref048","first-page":"204","article-title":"Reduction of peripheral blood T cells producing IFN-\u03b3 and IL-17 after therapy with abatacept for rheumatoid arthritis","volume":"32","author":"M Scarsi","year":"2014","journal-title":"Clin Exp Rheumatol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0215192","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T13:25:09Z","timestamp":1574256309000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0215192"}},"subtitle":[],"editor":[{"given":"Masataka","family":"Kuwana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,11,20]]},"references-count":48,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,11,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0215192","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/593475","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,20]]}}}